Page 1 | Search Results | Blood | American Society of Hematology

1-20 of 36

Sort by

Sort Order Select

Journal Articles

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Blood (2014) 124 (21): 320.

https://doi.org/10.1182/blood.V124.21.320.320

Published: 2014

Journal Articles

Use Of a Quality Management System and Outcome After Hematopoietic Stem Cell Transplantation

Per T. Ljungman, MD, PhD, Ronald Brand, PhD, Eoin McGrath, van Biezen Anja, Anna Sureda, MD, Helen Baldomero, Christian Chabannon, MD, PhD, Jane F. Apperley, MBChB, FRCP, FRCPath, Alois Gratwohl, MD

Blood (2013) 122 (21): 2945.

https://doi.org/10.1182/blood.V122.21.2945.2945

Published: 2013

Journal Articles

Gender influences the birth order effect in HLA-identical stem cell transplantation

Miranda P. Dierselhuis, Eric Spierings, Ronald Brand, Matthijs Hendriks, Angelica Canossi, Harry Dolstra, Jean-François Eliaou, Jürgen Enczmann, Thibaut Gervais, Brigitte Kircher, David Laurin, Pascale Loiseau, Ruhena Sergeant, Els Goulmy

Blood (2013) 121 (23): 4809–4811.

https://doi.org/10.1182/blood-2013-02-485722

Published: 2013

Journal Articles

Donor CMV Status Influence On the Outcome of Allogeneic Stem Cell Transplantation (HSCT); A Study by the Infectious Diseases Working Party (IDWP) of the EBMT

Per T. Ljungman, MD, PhD, Ronald Brand, PhD, Rafael De La Camara, MD, Catherine Cordonnier, Hermann Einsele, MD, Jan Styczynski, MD, PhD, Katherine N. Ward, MD, Simone Cesaro, MD

Blood (2012) 120 (21): 465.

https://doi.org/10.1182/blood.V120.21.465.465

Published: 2012

Journal Articles

Impact of Graft-Versus-Host Disease On Relapse After Allogeneic Hematopoietic Stem Cell Transplantation, an EBMT Megafile Study

Martin Stern, MD, Liesbeth C. de Wreede, PhD, Ronald Brand, PhD, Anja van Biezen, Peter Dreger, MD, Mohamad Mohty, MD, PhD, Theo M. de Witte, Nicolaus Kröger, Tapani Ruutu, MD, PhD

Blood (2012) 120 (21): 469.

https://doi.org/10.1182/blood.V120.21.469.469

Published: 2012

Journal Articles

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Blood (2011) 118 (21): 1019.

https://doi.org/10.1182/blood.V118.21.1019.1019

Published: 2011

Journal Articles

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

Mauricette Michallet, Peter Dreger, Laurent Sutton, Ronald Brand, Sue Richards, Marleen van Os, Mohamad Sobh, Sylvain Choquet, Bernadette Corront, Claire Dearden, Alois Gratwohl, Wolfgang Herr, Daniel Catovsky, Michael Hallek, Theo de Witte, Dietger Niederwieser, Michel Leporrier, Donald Milligan

Blood (2011) 117 (5): 1516–1521.

https://doi.org/10.1182/blood-2010-09-308775

Published: 2011

Journal Articles

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

Blood (2009) 114 (26): 5264–5270.

https://doi.org/10.1182/blood-2009-07-234880

Published: 2009

Journal Articles

High Impact of Human Leukocyte Antigen Matching On Overall Survival and Transplant Related Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Long-Term Study From the EBMT Registry.

Mauricette Michallet, MD, PhD, Mohamad Sobh, Pharm.M, Stéphane Morisset, MSc, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, MD, Nigel H. Russell, MD, Leo Verdonck, MD, Donald Milligan, MD, Nathalie Dhedin, MD, Tomas Kozak, Marc Boogaerts, MD, PhD, Juergen Finke, MD, Valérie Dubois, MD, Anja van Biezen, Ronald Brand, Theo de Witte, MD, Peter Dreger, MD

Blood (2009) 114 (22): 2286.

https://doi.org/10.1182/blood.V114.22.2286.2286

Published: 2009

Journal Articles

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

Mauricette Michallet, MD, PhD, Peter Dreger, MD, PhD, Laurent Sutton, MD, Ronald Brand, Sue Richards, Anja van Biezen, Mohamad Sobh, Pharm.M, Alois Gratwohl, MD, Karin Kolbe, MD, Claire E. Dearden, MD, Michael Hallek, T. M. de Witte, MD, PhD, Dietger W. Niederwieser, MD, Michel Leporrier, MD, Donald Milligan, MD

Blood (2009) 114 (22): 877.

https://doi.org/10.1182/blood.V114.22.877.877

Published: 2009

Journal Articles

T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective EBMT Analysis.

Johannes Schetelig, Donald Milligan, MD, MBChB, Dietger Niederwieser, Liisa Volin, J. Maertens, Alois Gratwohl, Martin Bornhaeuser, Michel Van Gelder, MD, PhD, Ronald Brand, T. M. de Witte, Peter Dreger

Blood (2009) 114 (22): 2307.

https://doi.org/10.1182/blood.V114.22.2307.2307

Published: 2009

Journal Articles

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kröger, MD, Avichai Shimoni, Georgia Schilling, Rainer Schwerdtfeger, MD, Martin Bornhäuser, Arnon Nagler, Axel R. Zander, Marion Heinzelmann, Ronald Brand, Goesta Gahrton, MD, PhD, Currly Morris, Dietger Niederwieser, T. M. de Witte

Blood (2009) 114 (22): 2308.

https://doi.org/10.1182/blood.V114.22.2308.2308

Published: 2009

Journal Articles

Donor Lymphocyte Infusions (DLI) After Peripheral Blood Stem Cell Transplantation. A Retrospective Analysis of 357 Patients by the Chronic Leukemias Working Party EBMT.

Grzegorz Wladyslaw Basak, Anja van Biezen, Ronald Brand, Christoph Schmid, Cesare Guglielmi, Anton Schattenberg, Richard Szydlo, Peter A. Von Dem Borne, Leo Verdonck, Donald W. Bunjes, Wieslaw Wiktor-Jedrzejczak, Eduardo Olavarria, Theo de Witte

Blood (2009) 114 (22): 3309.

https://doi.org/10.1182/blood.V114.22.3309.3309

Published: 2009

Journal Articles

Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT.

Kate Cwynarski, MD, PhD, Anja van Biezen, Ronald Brand, Marijke Scholten, Bernd Metzner, Mohamad Mohty, MD, PhD, Vladimir Koza, MD, Maija Itala-Remes, Fabio Ciceri, MD, Arnon Nagler, MD, T. M. de Witte, Anna Sureda, MD, PhD, Peter Dreger

Blood (2009) 114 (22): 3360.

https://doi.org/10.1182/blood.V114.22.3360.3360

Published: 2009

Journal Articles

Comparison of Allogeneic Stem Cell Transplantation and Best Supportive Care in Elderly Patients with Advanced MDS.

Nicolaus Kröger, Hein Putter, Ronald Brand, Andrea Kündgen, T. M. de Witte, Ulrich Germing

Blood (2009) 114 (22): 3363.

https://doi.org/10.1182/blood.V114.22.3363.3363

Published: 2009

Journal Articles

Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Michel Van Gelder, MD, PhD, Johannes Schetelig, Liisa Volin, Johan Maertens, Gerard Socié, Eefke Petersen, MD, Henrike Thomssen, MD, Anja Biezen, Ronald Brand, T. M. de Witte, Nicolaus Kröger, MD

Blood (2009) 114 (22): 293.

https://doi.org/10.1182/blood.V114.22.293.293

Published: 2009

Journal Articles

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Mauricette Michallet, MD, PhD, Quoc Hung Le, MD, Peter Dreger, Mohamad Sobh, PhD, Dietger Niederwieser, MD, Vladimir Koza, MD, Tapani Ruutu, Nigel H. Russell, MD, Leo Verdonck, Donald Milligan, MD, MBChB, Nathalie Dhedin, Tomas Kozak, MD, PhD, Marc Boogaerts, MD, PhD, Juergen Finke, Nathalie Tedone, Anja Van Biezen, Ronald Brand, Theo de Witte on behalfhe European Group for Blood Marrow Transplantation

Blood (2008) 112 (11): 566.

https://doi.org/10.1182/blood.V112.11.566.566

Published: 2008

Journal Articles

Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse of Malignant Disease: Retrospective Analysis of Outcome and Predictive Factors

Tapani Ruutu, Ronald Brand, Anja van Biezen, Vanderson Rocha, Anna Sureda, André Tichelli, Hermann Einsele, Giorgio Dini, Marco Bregni, Laurent Garderet, Jane Apperley, Alois Gratwohl, Dietger Niederwieser, Theo de Witte

Blood (2008) 112 (11): 339.

https://doi.org/10.1182/blood.V112.11.339.339

Published: 2008

Journal Articles

Allogeneic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndrome (t-MDS) and Acute Myeloid Leukemia. A Report from the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Nicolaus Kroeger, MD, Ronald Brand, MD, Anja van Biezen, Dietger Niederwieser, MD, Theo de Witte, MD

Blood (2007) 110 (11): 252.

https://doi.org/10.1182/blood.V110.11.252.252

Published: 2007

Journal Articles

Impact of the Donor Recipient Sex Combination in Hematopoietic Stem Cell Transplantation: H-Y as a Model for the Interaction between Major and Minor Histocompatibility Antigens.

Alois Gratwohl, Martin Stern, Ronald Brand, Theo de Witte, Anna Sureda, Vanderson Rocha, Jakob Passweg, Helen Baldomero, Dietger Niederwieser

Blood (2007) 110 (11): 481.

https://doi.org/10.1182/blood.V110.11.481.481

Published: 2007

NARROW

Reduced Intensity Vs. Standard Conditioning Followed By Allogeneic Stem Cell Transplantation for Patients with MDS or Secondary AML: A Prospective, Randomized Phase III Study of the Chronic Malignancies Working Party of the EBMT (RICMAC-Trial)

Use Of a Quality Management System and Outcome After Hematopoietic Stem Cell Transplantation

Gender influences the birth order effect in HLA-identical stem cell transplantation

Donor CMV Status Influence On the Outcome of Allogeneic Stem Cell Transplantation (HSCT); A Study by the Infectious Diseases Working Party (IDWP) of the EBMT

Impact of Graft-Versus-Host Disease On Relapse After Allogeneic Hematopoietic Stem Cell Transplantation, an EBMT Megafile Study

Long Term Follow-up of the Prospective Multicenter Study of reduced-Intensity Allogeneic Stem Cell Transplantation for Primary or Post ET/PV Myelofibrosis

Autologous hematopoietic stem cell transplantation in chronic lymphocytic leukemia: results of European intergroup randomized trial comparing autografting versus observation

Allogeneic stem cell transplantation after reduced-intensity conditioning in patients with myelofibrosis: a prospective, multicenter study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation

High Impact of Human Leukocyte Antigen Matching On Overall Survival and Transplant Related Mortality in Allogeneic Hematopoietic Stem Cell Transplantation for CLL: Long-Term Study From the EBMT Registry.

Autologous Hematopoietic Stem Cell Transplantation (autoHSCT) in CLL: First Results of An EBMT Randomized Trial Comparing Autotransplant Versus Wait and Watch.

T-Cell Depletion in Allogeneic Hematopoietic Cell Transplantation for Chronic Lymphocytic Leukemia: A Retrospective EBMT Analysis.

Unrelated Stem Cell Transplantation After Reduced Intensity Conditioning for Patients with Multiple Myeloma Relapsing After Autologous Transplantation A Prospective Multicenter Phase II Study of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Donor Lymphocyte Infusions (DLI) After Peripheral Blood Stem Cell Transplantation. A Retrospective Analysis of 357 Patients by the Chronic Leukemias Working Party EBMT.

Autologous and Allogeneic Stem Cell Transplantation for Richter's Transformation: A Retrospective Analysis From the Chronic Leukaemia Working Party and Lymphoma Working Party of the EBMT.

Comparison of Allogeneic Stem Cell Transplantation and Best Supportive Care in Elderly Patients with Advanced MDS.

Monosomal Karyotype Predicts Poor Outcome for MDS/sAML Patients with Chromosome 7 Abnormalities After Allogeneic Stem Cell Transplantation for MDS/sAML. A Study of the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Standard and Reduced Intensity Allogeneic Hematopoietic Stem Cell Transplantations (HSCT) from Related and Unrelated Donors for Chronic Lymphocytic Leukemia (CLL). a Long-Term Follow-up (10 years) Study from the EBMT Registry. (CLL Sub-Committee on Behalf of EBMT CLWP)

Second Allogeneic Hematopoietic Stem Cell Transplantation for Relapse of Malignant Disease: Retrospective Analysis of Outcome and Predictive Factors

Allogeneic Stem Cell Transplantation for Therapy-Related Myelodysplastic Syndrome (t-MDS) and Acute Myeloid Leukemia. A Report from the MDS Subcommittee of the Chronic Leukemia Working Party of the European Group for Blood and Marrow Transplantation (EBMT).

Impact of the Donor Recipient Sex Combination in Hematopoietic Stem Cell Transplantation: H-Y as a Model for the Interaction between Major and Minor Histocompatibility Antigens.

Email alerts

ASH Publications

American Society of Hematology

Email alerts

ASH Publications

American Society of Hematology

This Feature Is Available To Subscribers Only